Reading between the lines it's safe to say no mishaps or adverse events. And hopefully no pacemakers.
Hopefully data will be submitted to the FDA by December.
- Forums
- ASX - By Stock
- Ann: Anteris Completes DurAVR THV EFS Enrolment
Reading between the lines it's safe to say no mishaps or adverse...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.15 |
Change
0.350(2.97%) |
Mkt cap ! $256.8M |
Open | High | Low | Value | Volume |
$11.80 | $12.15 | $11.21 | $376.0K | 32.22K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 139 | $12.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.15 | 830 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 841 | 11.900 |
1 | 1000 | 11.800 |
1 | 5000 | 11.720 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
Price($) | Vol. | No. |
---|---|---|
12.150 | 830 | 1 |
12.250 | 175 | 1 |
12.400 | 198 | 1 |
12.800 | 1000 | 1 |
12.850 | 1000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
AVR (ASX) Chart |